Lineage Cell Therapeutics, Inc. · AMEX:LCTX
NEAL C. BRADSHER reported a 23.10% stake in Lineage Cell Therapeutics, Inc. (Schedule 13D/A)
Event Nov 12, 2025 · Filed Nov 14, 2025
NEAL C. BRADSHER reported a 23.10% stake in Lineage Cell Therapeutics, Inc., 57,848,357 shares, with active intent on Nov 12, 2025. Filed Nov 14, 2025 (Schedule 13D/A).
- Stake
- 23.10%
- Shares
- 57,848,357
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BROADWOOD PARTNERS, L.P. | 23.00% | 57,455,729 |
| BROADWOOD CAPITAL, INC. | 23.00% | 57,455,729 |
| NEAL C. BRADSHER | 23.10% | 57,848,357 |
Source
Related
- Lineage Cell Therapeutics, Inc.
- Neal C. Bradsher
- Lineage Cell Therapeutics, Inc. shareholders
- Schedule 13D/A · Neal C. Bradsher · Jan 28, 2025
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · Chernett Jorey · Sep 26, 2025
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G · BlackRock, Inc. · Apr 24, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025